Steele Lea, Lockridge Oksana, Gerkovich Mary M, Cook Mary R, Sastre Antonio
Veterans Health Research Program, Baylor University Institute of Biomedical Studies, One Bear Place # 97261, Waco, TX 76798, USA.
Environ Health. 2015 Jan 9;14:4. doi: 10.1186/1476-069X-14-4.
Epidemiologic studies have implicated wartime exposures to acetylcholinesterase (AChE)-inhibiting chemicals as etiologic factors in Gulf War illness (GWI), the multisymptom condition linked to military service in the 1991 Gulf War. It is unclear, however, why some veterans developed GWI while others with similar exposures did not. Genetic variants of the enzyme butyrylcholinesterase (BChE) differ in their capacity for metabolizing AChE-inhibiting chemicals, and may confer differences in biological responses to these compounds. The current study assessed BChE enzyme activity and BChE genotype in 1991 Gulf War veterans to evaluate possible association of this enzyme with GWI.
This case-control study evaluated a population-based sample of 304 Gulf War veterans (144 GWI cases, meeting Kansas GWI criteria, and 160 controls). BChE enzyme activity levels and genotype were compared, overall, in GWI cases and controls. Potential differences in risk associated with cholinergic-related exposures in theater were explored using stratified analyses to compare associations between GWI and exposures in BChE genetic and enzyme activity subgroups.
Overall, GWI cases and controls did not differ by mean BChE enzyme activity level or by BChE genotype. However, for the subgroup of Gulf War veterans with less common, generally less active, BChE genotypes (K/K, U/AK, U/A, A/F, AK/F), the association of wartime use of pyridostigmine bromide (PB) with GWI (OR=40.00, p=0.0005) was significantly greater than for veterans with the more common U/U and U/K genotypes (OR=2.68, p=0.0001).
Study results provide preliminary evidence that military personnel with certain BChE genotypes who used PB during the 1991 Gulf War may have been at particularly high risk for developing GWI. Genetic differences in response to wartime exposures are potentially important factors in GWI etiology and should be further evaluated in conjunction with exposure effects.
流行病学研究表明,战时接触乙酰胆碱酯酶(AChE)抑制性化学物质是海湾战争综合征(GWI)的病因之一,GWI是一种与1991年海湾战争中的军事服役相关的多症状疾病。然而,尚不清楚为什么一些退伍军人患上了GWI,而其他有类似接触史的人却没有。丁酰胆碱酯酶(BChE)的基因变异在代谢AChE抑制性化学物质的能力上存在差异,可能导致对这些化合物的生物学反应有所不同。本研究评估了1991年海湾战争退伍军人的BChE酶活性和BChE基因型,以评估该酶与GWI之间可能存在的关联。
这项病例对照研究评估了一个基于人群的304名海湾战争退伍军人样本(144例符合堪萨斯州GWI标准的GWI病例和160名对照)。总体上,比较了GWI病例和对照的BChE酶活性水平和基因型。通过分层分析探讨了战区与胆碱能相关接触相关的风险潜在差异,以比较GWI与BChE基因和酶活性亚组中接触之间的关联。
总体而言,GWI病例和对照在平均BChE酶活性水平或BChE基因型方面没有差异。然而,对于BChE基因型较不常见、通常活性较低的海湾战争退伍军人亚组(K/K、U/AK、U/A、A/F、AK/F),战时使用溴吡斯的明(PB)与GWI的关联(OR = 40.00,p = 0.0005)显著大于具有更常见的U/U和U/K基因型的退伍军人(OR = 2.68,p = 0.0001)。
研究结果提供了初步证据,表明在1991年海湾战争期间使用PB的具有某些BChE基因型的军事人员可能患GWI的风险特别高。战时接触反应的基因差异可能是GWI病因中的重要因素,应结合接触效应进行进一步评估。